These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 26895076)
21. The basal ganglia: a substrate for fatigue in multiple sclerosis. Téllez N; Alonso J; Río J; Tintoré M; Nos C; Montalban X; Rovira A Neuroradiology; 2008 Jan; 50(1):17-23. PubMed ID: 17955232 [TBL] [Abstract][Full Text] [Related]
22. Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patients. Fu L; Wolfson C; Worsley KJ; De Stefano N; Collins DL; Narayanan S; Arnold DL NMR Biomed; 1996 Dec; 9(8):339-46. PubMed ID: 9176888 [TBL] [Abstract][Full Text] [Related]
23. Hippocampal structures: anteroposterior N-acetylaspartate differences in patients with epilepsy and control subjects as shown with proton MR spectroscopic imaging. Vermathen P; Laxer KD; Matson GB; Weiner MW Radiology; 2000 Feb; 214(2):403-10. PubMed ID: 10671587 [TBL] [Abstract][Full Text] [Related]
24. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder. Iranzo A; Santamaria J; Pujol J; Moreno A; Deus J; Tolosa E Sleep; 2002 Dec; 25(8):867-70. PubMed ID: 12489892 [TBL] [Abstract][Full Text] [Related]
25. Progressive decrease of N-acetylaspartate to total creatine ratio in the pregenual anterior cingulate cortex in patients with major depressive disorder: longitudinal 1H-MR spectroscopy study. Tae WS; Kim SS; Lee KU; Nam EC; Koh SH Acta Radiol; 2014 Jun; 55(5):594-603. PubMed ID: 24031048 [TBL] [Abstract][Full Text] [Related]
26. Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis. Wu X; Hanson LG; Skimminge A; Sorensen PS; Paulson OB; Mathiesen HK; Blinkenberg M Neurol Res; 2014 Aug; 36(8):701-8. PubMed ID: 24620975 [TBL] [Abstract][Full Text] [Related]
27. [The metabolic abnormalities in plaques of multiple sclerosis patients - the assessment in proton MR spectroscopy (1HMRS)]. Szafirska M; Urbanik A; Róg T Przegl Lek; 2013; 70(5):328-34. PubMed ID: 23944105 [TBL] [Abstract][Full Text] [Related]
28. Biochemical Correlations with Fatigue in Multiple Sclerosis Detected by MR 2D Localized Correlated Spectroscopy. Arm J; Al-Iedani O; Ribbons K; Lea R; Lechner-Scott J; Ramadan S J Neuroimaging; 2021 May; 31(3):508-516. PubMed ID: 33615583 [TBL] [Abstract][Full Text] [Related]
29. MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter. Vrenken H; Barkhof F; Uitdehaag BM; Castelijns JA; Polman CH; Pouwels PJ Magn Reson Med; 2005 Feb; 53(2):256-66. PubMed ID: 15678547 [TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis. Staffen W; Zauner H; Mair A; Kutzelnigg A; Kapeller P; Stangl H; Raffer E; Niederhofer H; Ladurner G J Neuropsychiatry Clin Neurosci; 2005; 17(3):357-63. PubMed ID: 16179658 [TBL] [Abstract][Full Text] [Related]
31. Proton spectroscopy in the narcoleptic syndrome. Is there evidence of a brainstem lesion? Ellis CM; Simmons A; Lemmens G; Williams SC; Parkes JD Neurology; 1998 Feb; 50(2 Suppl 1):S23-6. PubMed ID: 9484419 [TBL] [Abstract][Full Text] [Related]
32. Cerebral metabolism, magnetic resonance spectroscopy and cognitive dysfunction in early multiple sclerosis: an exploratory study. Blinkenberg M; Mathiesen HK; Tscherning T; Jønsson A; Svarer C; Holm S; Sellebjerg F; Paulson OB; Hanson LG; Sorensen PS Neurol Res; 2012 Jan; 34(1):52-8. PubMed ID: 22196862 [TBL] [Abstract][Full Text] [Related]
33. Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging. Kirov II; Liu S; Tal A; Wu WE; Davitz MS; Babb JS; Rusinek H; Herbert J; Gonen O Hum Brain Mapp; 2017 Aug; 38(8):4047-4063. PubMed ID: 28523763 [TBL] [Abstract][Full Text] [Related]
34. Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis. Parry A; Corkill R; Blamire AM; Palace J; Narayanan S; Arnold D; Styles P; Matthews PM J Neurol; 2003 Feb; 250(2):171-8. PubMed ID: 12574947 [TBL] [Abstract][Full Text] [Related]
35. Effects of overnight sleep restriction on brain chemistry and mood in women with unipolar depression and healthy controls. Bernier D; Bartha R; Devarajan S; Macmaster FP; Schmidt MH; Rusak B J Psychiatry Neurosci; 2009 Sep; 34(5):352-60. PubMed ID: 19721845 [TBL] [Abstract][Full Text] [Related]
36. 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review. Caramanos Z; Narayanan S; Arnold DL Brain; 2005 Nov; 128(Pt 11):2483-506. PubMed ID: 16230321 [TBL] [Abstract][Full Text] [Related]
37. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. Richards TL AJR Am J Roentgenol; 1991 Nov; 157(5):1073-8. PubMed ID: 1927795 [TBL] [Abstract][Full Text] [Related]
38. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging. Oh J; Pelletier D; Nelson SJ Arch Neurol; 2004 Jul; 61(7):1081-6. PubMed ID: 15262739 [TBL] [Abstract][Full Text] [Related]
39. Proton magnetic resonance spectroscopy of normal appearing white matter in asymptomatic relatives of multiple sclerosis patients. Siger-Zajdel M; Selmaj K Eur J Neurol; 2006 Mar; 13(3):296-8. PubMed ID: 16618349 [TBL] [Abstract][Full Text] [Related]
40. Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis. Sarchielli P; Presciutti O; Tarducci R; Gobbi G; Alberti A; Pelliccioli GP; Chiarini P; Gallai V J Neurol; 2002 Jul; 249(7):902-10. PubMed ID: 12140676 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]